Methods for long-range sequence analysis of nucleic acids

• US 20060073501A1
• Filed: 09/08/2005
• Published: 04/06/2006
• Est. Priority Date: 09/10/2004
• Status: Abandoned Application

• Current Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Original Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Inventors: Van Den Boom, Dirk Johannes, Boecker, Sebastian
• Application Number:
  US11/222,991
• Publication Number:
  US 20060073501A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2563/167 Mass label
• CPC Class Codes: C12Q 2565/501 being an array of oligonucleotides

Abstract

Provided are methods for sequencing a target nucleic acid by fragmenting a target nucleic acid, hybridizing fragments to an array of capture oligonucleotides, determining the mass of the hybridized fragments, and constructing a nucleotide sequence of the target nucleic acid from the mass measurements.

Claims

1. A method for sequencing a target nucleic acid, comprising:

a) generating overlapping fragments of a target nucleic acid;

b) contacting the fragments with an array of capture oligonucleotides under conditions that do not eliminate mismatched hybridization of the fragments to the capture oligonucleotides;

c) measuring the mass of hybridized fragments at each array locus by mass spectrometry; and

d) constructing the nucleotide sequence of the target nucleic acid from the mass measurements.

3. The method of claim 1, wherein the constructing step d) comprises:

tentatively constructing a nucleotide sequence containing a hypothetical nucleotide at a nucleotide locus;

predicting the fragmentation of the tentative nucleotide sequence, predicting which predicted fragments hybridize to a capture oligonucleotide, and predicting masses of hybridized predicted fragments;

comparing the predicted masses of fragments with experimentally observed masses; and

if the predicted masses match the observed masses, identifying the nucleotide locus in the target nucleic acid molecule as containing the hypothetical nucleotide.

4. The method of claim 3, wherein the step of tentatively constructing further includes tentatively constructing nucleotide sequences containing each of the four typical nucleotides at a nucleotide locus, and the predicting and comparing steps are performed for all tentative nucleotide sequences, and tentative nucleotide sequence for which the predicted masses most closely match the observed mass is identified as the nucleotide sequence in the target nucleic acid molecule.

5. The method of claim 3, wherein the tentatively constructing, predicting, comparing and identifying steps are iterated, wherein each iteration includes tentatively constructing an increasingly longer nucleotide sequence containing a hypothetical nucleotide at a nucleotide locus.

6. The method of claim 1, wherein the constructing step d) comprises:

establishing limits for fragment products of nucleic acid fragmentation;

establishing limits for nucleic acid fragments that can hybridize to a particular capture oligonucleotide;

predicting possible masses that can be observed in a mass spectrum of nucleotide fragments hybridized to the capture oligonucleotide;

comparing observed masses to the predicted masses that can be observed to identify possible sequences that could be present and/or to identify sequences that are not present; and

repeating the comparing, establishing, predicting and comparing steps for one or more additional capture oligonucleotides to thereby decrease the number of possible sequences that could be present,

whereby at least a portion of the nucleotide sequence of the target nucleic acid molecule is identified.

7. The method of claim 1, wherein the fragments are generated using a fragmentation method selected from the group consisting of enzymatic fragmentation, physical fragmentation, chemical fragmentation, and combinations thereof.

8. The method of claim 1, wherein the fragments are generated by enzymatic fragmentation using one or more enzymes, and wherein the one or more enzymes used for enzymatic fragmentation are selected from the group consisting of a non-specific RNase, a non-specific DNase, at least two double-base cutters, a preferentially-cleaving endonuclease, a restriction endonuclease, a single-base cutter, a double-base cutter, and combinations thereof.

9. The method of claim 1, wherein the fragments statistically range in a size selected from the group of size ranges consisting of 5-50 bases, 10-40 bases, 11-35 bases, and 12-30 bases.

10. The method of claim 1, wherein fewer than all theoretical combinations of capture oligonucleotide sequences are present on the array.

15. The method of claim 1, wherein the array of capture oligonucleotides are immobilized on a solid-support selected from the group consisting of hybridization chip, pin tool, bead, polystyrene, polycarbonate, polypropylene, nylon, glass, dextran, chitin, sand, pumice, agarose, polysaccharides, dendrimers, buckyballs, polyacrylamide, silicon, metal, rubber, microtiter dish, microtiter well, glass slide, silicon chip, nitrocellulose sheet, and nylon mesh.

2. A method for sequencing a target nucleic acid, comprising

a) generating overlapping fragments of a target nucleic acid;

b) contacting the fragments with an array of capture oligonucleotides, wherein one or more of the capture oligonucleotides are partially degenerate;

c) measuring the mass of fragments hybridized to the capture oligonucleotides at each array position by mass spectrometry; and

d) constructing a nucleotide sequence of the target nucleic acid the mass measurements.

11. The method of claim 2, wherein the partially degenerate oligonucleotides comprise a number of degenerate positions selected from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10.

12. The method of claim 11, wherein each degenerate position comprises a degenerate base selected from the group consisting of a universal base and a semi-universal base.

13. The method of claim 12, wherein the universal base is selected from the group consisting of Inosine, Xanthosine, 3-nitropyrrole, 4-nitroindole, 5-nitroindole, 6-nitroindole, nitroimidazole, 4-nitropyrazole, 5-aminoindole, 4-nitrobenzimidazole, 4-aminobenzimidazole, phenyl C-ribonucleoside, benzimidazole, 5-fluoroindole, indole;

acyclic sugar analogs, derivatives of hypoxanthine, imidazole 4,5-dicarboxamide, 3-nitroimidazole, 5-nitroindazole;

aromatic analogs, benzene, naphthalene, phenanthrene, pyrene, pyrrole, difluorotoluene;

isocarbostyril nucleoside derivatives, MICS, ICS; and

hydrogen-bonding analogs, N8-pyrrolopyridine.

14. The method of claim 12, wherein the semi-universal base is selected from the group consisting of a base that hybridizes preferentially to purines A and G, a base that hybridizes to preferentially to pyrimidines C and T, a base that hybridizes to preferentially to pyrimidines C and U, 6H,8H-3,4-dihydropyrimido[4,5-c][1,2]oxazin-7-one, and N6-methoxy-2,6-diaminopurine.

16. A method for controlling the complexity of a mass spectrum of target nucleic acid fragments, comprising:

(a) modulating the number of different nucleotide sequences in a first region of target nucleic acid fragments that hybridize to the capture oligonucleotide probe, whereby two or more target nucleic acid fragments containing different nucleotide sequences in the respective first regions hybridize to the capture oligonucleotide probe; and

(b) measuring the mass of the target nucleic acid fragments hybridized to the capture oligonucleotide probe by mass spectrometry,

whereby the complexity of the mass spectrum is controlled.

17. The method of claim 16, further comprising a step of controlling the length of the target nucleic acid fragments prior to measuring the mass of the target nucleic acid fragments.

18. The method of claim 16, wherein the capture oligonucleotide probe contains one or more degenerate bases.

19. The method of claim 18, wherein the degenerate bases are selected from the group consisting of universal bases and semi-universal bases.

20. The method of claim 16, wherein one or more of the target nucleic acid fragments further contain a second region that does not hybridize to the capture oligonucleotide probe.

21. The method of claim 20, wherein, of the one or more target nucleic acid fragments that contain second regions, at least two contain different nucleotide sequences in their respective second regions.

22. The method of claim 20, wherein the second regions of the one or more target nucleic acid fragments contain one or more known nucleotides at nucleotide positions at an end of the target nucleic acid fragments selected from the group consisting of the 3′

end and the 5′

end.

23. The method of claim 16, wherein the step of controlling the length of target nucleic acid fragments further includes base-specific cleavage.

24. The method of claim 16, wherein the target nucleic acid fragments are hybridized to an array of capture oligonucleotide probes, wherein the array contains a plurality of positions, and the nucleotide sequence of the capture oligonucleotide probes at each array position differs from the nucleotide sequence of capture oligonucleotide probes at all other array positions.

25. A method of identifying a portion of a target nucleic acid, comprising:

(a) collecting a mass spectrum with controlled complexity according to the method of claim 16;

and

(b) comparing the one or more target nucleic acid fragment masses with one or more masses of one or more reference nucleic acids,

wherein a correlation between one or more target nucleic acid fragment masses and one or more reference masses identifies a portion of the target nucleic acid as corresponding to the reference nucleic acid or corresponding to a portion of the reference nucleic acid.

26. The method of claim 25, wherein the one or more reference masses of at least one reference nucleic acid are calculated.

27. The method of claim 25, wherein the one or more reference masses of at least one reference nucleic acid are experimentally measured.

28. The method of claims 25, wherein the target nucleic acid fragments are formed using a method selected from sequence-specific fragmentation and non-specific fragmentation.

29. The method of claim 25, wherein the portion of the target nucleic acid identified contains a SNP.

30. A composition for identifying a portion of a target nucleic acid, comprising:

(a) an array of two or more capture oligonucleotides on a solid support, wherein at least one capture oligonucleotide is partially degenerate; and

(b) a mass spectrometer operably coupled to the array.

31. The composition of claim 30, further comprising a computer program for constructing a nucleotide sequence of the target nucleic acid from a set of mass signals acquired from nucleic acid molecules that hybridize to the capture oligonucleotides.